Marc-André Mahé

Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer

Jean‐Pierre Gérard, D. Azria, S. Gourgou-Bourgade et al. · Journal of Clinical Oncology · 2012 · 432 citations · Full text

Medicine, Oncology, Surgery +17

Impact of Postoperative Radiation Therapy on Survival in Patients With Complete Resection and Stage I, II, or IIIA Non–Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial

Jean‐Yves Douillard, Rafael Rosell, Mario De Lena et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 362 citations

Medicine, Oncology, Surgery +17

Pretreatment ¹⁸F-FDG PET/CT Radiomics Predict Local Recurrence in Patients Treated with Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer: A Multicentric Study

Gurvan Dissaux, Dimitris Visvikis, Ronrick Da‐ano et al. · Journal of Nuclear Medicine · 2019 · 169 citations · Full text

Medicine, Nuclear Medicine, Radiation Oncology +17

Long-term complications of total body irradiation in adults

Olivier Thomas, Marc-André Mahé, L. Campion et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 119 citations

Medicine, Radiation Oncology, Surgery +14

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

D. Azria, J. Doyen, Marta Jarlier et al. · Annals of Oncology · 2017 · 106 citations · Full text

Medicine, Oncology, Radiation Oncology +15